Getein Biotech, Inc. Class ASSE: 603387

"Getein Biotech, Inc"Announcement on Expected Increase in Semi-annual Performance for 2026

Jul 15, 2026 · Issued by Getein Biotech, Inc. Class A via Shanghai Stock Exchange

Announcement on Expected Increase in Semi-annual Performance for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from Getein Biotech, Inc. Class A

"Getein Biotech, Inc"Announcement on the Shareholdings of the Top Ten Shareholders and the Top Ten Holders of Unrestricted Shares Prior to the Share RepurchaseJul 9
"Getein Biotech, Inc"Announcement on the Initial Repurchase of Shares through Call AuctionJul 8
Announcement on Implementation of Dividend Distribution for 2025Jun 12
Announcement on Outline of the Online Performance Briefing for 2025 and Q1 2026May 28

All Getein Biotech, Inc. Class A news releases